Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on New Diagnosis and Treatment Technologies for Major Traditional Chinese Medicine Advantage Diseases - Multi-Omics and Artificial Intelligence-Driven Innovative TCM Diagnosis and Treatment Technologies for Diabetic Nephropathy

NCT07459946 is registered in ClinicalTrials.gov with Jiazhen Yin as lead sponsor.

NCT NCT07459946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on New Diagnosis and Treatment Technologies for Major Traditional Chinese Medicine Advantage Diseases - Multi-Omics and Artificial Intelligence-Driven Innovative TCM Diagnosis and Treatment Technologies for Diabetic Nephropathy
Lead sponsor
Jiazhen Yin
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 12, 2026
Completion date
December 31, 2026
Enrollment
198 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure/ kidney disease, diabetic nephropathy type 2